Mr Mrs Miss Ms Dr Other

Mrs
Ellie
Purnell

Patent Director

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Ellie is a UK and European qualified patent attorney with a strong academic background in Life Sciences, particularly in Plant Sciences. In addition, Ellie holds a qualification as a Patent Attorney Litigator with advocacy experience working on oppositions and appeals before the European Patent Office. She specialises in dealing with technology in the Gene Editing, Antibody, Peptide, AgBio, and Microbiology fields. Ellie is interested in helping SMEs, start-ups and spin-outs maximise their potential by exploiting IP protection and good IP management. She enjoys working with challenging IP portfolios and developing IP strategies. In particular for those cases experiencing difficulty in European prosecution.

Ellie has worked with all types of clients, from multinational companies including AstraZeneca, Novartis, and Dow AgroSciences, to small start ups and spin outs such as Pepgen and Tissue Regenix.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MA

(Cantab) Natural Sciences - Double First Class Honours

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Litigation and Advocacy Certificate - Nottingham Trent University - Distinction

Recognition

Senior Scholar and Honarary Senior Scholar of Gonville & Caius College, Cambridge

Awarded to undergraduates who achieved a first class in university examinations, achieved in 2009 and 2010

The Frank Smart Prize for Botany

Awarded to undergraduate who achieved highest overall marks in Plant Sciences, awarded in 2009 and 2010

The Keith Farewell Prize

Awarded by CIPA to the patent trainee who achieved the highest mark in the P7 examination (UK trademark law)

Publications

CRISPR Edited T cells win the TvT Battle

View publication online

Patenting antibodies in the US and Europe

View publication online

The EPO ‘How To’ guide for antibody applications in Europe

View publication online

AI solution to Levinthal's paradox

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

A look at the WIPO coronavirus tools

View publication online

Compulsory licences: the key to accessing inventions in the face of coronavirus?

View publication online

G3/19: An end to the saga…

View publication online

G3/19: A further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

G3/19: A Further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

Compulsory licences: the key to accessing inventions in the face of coronavirus?

View publication online

A look at the WIPO coronavirus tools

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

How a platform technology patent list can expedite covid-19 vaccine research

View publication online

The Patent Landscape Behind COVID-19 Vaccines

View publication online

Conferences: 2022

September 22nd 2022

BioCap Conference 2022

Attended

Event details

Conferences: 2021

July 2nd 2021

G1/21 hearing at the EPO - July

Attended

Event details

January 7th 2021

iBioIC

Attended

Event details

Conferences: 2020

November 4th 2020

Bionow Oncology Conference 2020

Attended

Event details

CSR

Ellie regularly holds tutorials for trainees within HGF, and has acted as an ongoing mentor for those trainees taking UK finals examinations.

She has also recently acted as a CIPA designated mentor for candidates re-taking the UK law exam (FD1).

In the past, Ellie held the position of the Northern Informals Secretary for several years organising social and educational events for trainees across the North of England, including organising and implementing a series of tutorials with tutors from different firms.

Related News

New Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Investing in Patents for Space Tech: Safeguarding Innovations in the Space Sector

The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …

Read article

End of EPO "10 day rule" from 1 November 2023 – 4 weeks to go

Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them.   This means that communications are deemed to …

Read article
Event - 21st, 28th November 2023

Dresden & Salzburg Seminar: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …

Event details
Event - 26th September 2023

Bioforward OBN Conference 2023

Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …

Event details

AI-Powered Personalised Medicine

The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.